Original articles
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
Raffaella Lionettia,
, Paola Piccolob,c, Ilaria Lencic, Massimo Sicilianod, Ubaldo Visco-Comandinia, Adriano De Santise, Maurizio Pompilid, Martina Milanac, Chiara Taibia, Serena Dell’Isolaf, Marzia Montalbanoa, Claudio Mastroiannig, Paola Beginih, Anna Rosa Garbugliai, Mario Angelicoc, Gianpiero D’Offizia
Corresponding author
raffaella.lionetti@inmi.it
Corresponding author at: Liver and Infectious Diseases, Lazzaro Spallanzani National Institute for Infectious Disease, Via portuense 292, 00149 Rome, Italy.
Corresponding author at: Liver and Infectious Diseases, Lazzaro Spallanzani National Institute for Infectious Disease, Via portuense 292, 00149 Rome, Italy.
a Liver and Infectious Diseases, Lazzaro Spallanzani National Institute for Infectious Disease, Rome, Italy
b Internal Medicine Unit, Fatebenefratelli Hospital Isola Tiberina, Rome, Italy
c Liver Unit, Tor Vergata University Hospital, Rome, Italy
d Gastroenterology and Liver Unit, Policlinico Gemelli, Catholic University, Rome, Italy
e Gastroenterology and Liver Unit, Policlinico Umberto I, Sapienza University, Rome, Italy
f Medicina Protetta-Infectious Diseases, Belcolle Hospital, Viterbo, Italy
g Infectious Diseases, Policlinico Umberto I, Sapienza University, Rome, Italy
h Liver Unit, Sant’Andrea University Hospital, Rome, Italy
i Laboratory of Virology, Lazzaro Spallanzani National Institute for Infectious Disease, Rome, Italy
Ver másRead
6378
Timeswas read the article
681
Total PDF
5697
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 75 | 3 | 78 |
| 2025 11 | 262 | 22 | 284 |
| 2025 10 | 179 | 10 | 189 |
| 2025 9 | 177 | 10 | 187 |
| 2025 8 | 152 | 9 | 161 |
| 2025 7 | 124 | 5 | 129 |
| 2025 6 | 83 | 4 | 87 |
| 2025 5 | 93 | 2 | 95 |
| 2025 4 | 89 | 1 | 90 |
| 2025 3 | 94 | 9 | 103 |
| 2025 2 | 77 | 6 | 83 |
| 2025 1 | 49 | 7 | 56 |
| 2024 12 | 51 | 2 | 53 |
| 2024 11 | 73 | 4 | 77 |
| 2024 10 | 52 | 2 | 54 |
| 2024 9 | 49 | 4 | 53 |
| 2024 8 | 53 | 6 | 59 |
| 2024 7 | 83 | 4 | 87 |
| 2024 6 | 72 | 7 | 79 |
| 2024 5 | 38 | 8 | 46 |
| 2024 4 | 51 | 3 | 54 |
| 2024 3 | 100 | 6 | 106 |
| 2024 2 | 139 | 12 | 151 |
| 2024 1 | 57 | 3 | 60 |
| 2023 12 | 53 | 10 | 63 |
| 2023 11 | 75 | 14 | 89 |
| 2023 10 | 114 | 10 | 124 |
| 2023 9 | 78 | 2 | 80 |
| 2023 8 | 76 | 7 | 83 |
| 2023 7 | 76 | 7 | 83 |
| 2023 6 | 56 | 9 | 65 |
| 2023 5 | 117 | 6 | 123 |
| 2023 4 | 91 | 4 | 95 |
| 2023 3 | 90 | 3 | 93 |
| 2023 2 | 63 | 1 | 64 |
| 2023 1 | 95 | 3 | 98 |
| 2022 12 | 70 | 6 | 76 |
| 2022 11 | 81 | 4 | 85 |
| 2022 10 | 65 | 8 | 73 |
| 2022 9 | 78 | 15 | 93 |
| 2022 8 | 65 | 9 | 74 |
| 2022 7 | 73 | 9 | 82 |
| 2022 6 | 95 | 13 | 108 |
| 2022 5 | 65 | 6 | 71 |
| 2022 4 | 77 | 9 | 86 |
| 2022 3 | 85 | 14 | 99 |
| 2022 2 | 77 | 9 | 86 |
| 2022 1 | 109 | 7 | 116 |
| 2021 12 | 90 | 17 | 107 |
| 2021 11 | 83 | 8 | 91 |
| 2021 10 | 110 | 12 | 122 |
| 2021 9 | 56 | 12 | 68 |
| 2021 8 | 61 | 13 | 74 |
| 2021 7 | 51 | 7 | 58 |
| 2021 6 | 59 | 8 | 67 |
| 2021 5 | 53 | 12 | 65 |
| 2021 4 | 172 | 27 | 199 |
| 2021 3 | 87 | 9 | 96 |
| 2021 2 | 64 | 11 | 75 |
| 2021 1 | 50 | 7 | 57 |
| 2020 12 | 54 | 5 | 59 |
| 2020 11 | 44 | 4 | 48 |
| 2020 10 | 13 | 3 | 16 |
| 2020 9 | 37 | 9 | 46 |
| 2020 8 | 35 | 4 | 39 |
| 2020 7 | 29 | 2 | 31 |
| 2020 6 | 23 | 7 | 30 |
| 2020 5 | 21 | 6 | 27 |
| 2020 4 | 69 | 5 | 74 |
| 2020 3 | 43 | 4 | 47 |
| 2020 2 | 16 | 3 | 19 |
| 2020 1 | 21 | 8 | 29 |
| 2019 12 | 20 | 27 | 47 |
| 2019 11 | 16 | 8 | 24 |
| 2019 10 | 18 | 10 | 28 |
| 2019 9 | 14 | 10 | 24 |
| 2019 8 | 6 | 13 | 19 |
| 2019 7 | 17 | 19 | 36 |
| 2019 6 | 30 | 34 | 64 |
| 2019 5 | 39 | 18 | 57 |
| 2019 4 | 0 | 5 | 5 |
Show all
